Skip to main content
. 2022 Nov 17;15(11):1427. doi: 10.3390/ph15111427

Figure 5.

Figure 5

(a) Representation of the interaction of fluconazole (in green), a known triazole antifungal drug, with the heme group (in red) in the active site of CYP51 from Saccharomyces cerevisiae; (b) Representation of the interaction of VT-1161 (in green), a tetrazole antifungal agent, with the heme group (in red) in the active site of CYP51 from Candida albicans. ChemBio3D was used to visualize (PDB 4WMZ and PDB 5TZ, respectively) [25,26].